$CLMT

Calumet, Inc. /DE (CLMT): Results of Operations and Financial Condition

Calumet, Inc. /DE (CLMT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Calumet Reports Second Quarter 2026 Results • Second Quarter 2026 net loss of $(95.9) million, or basic earnings per common share of $(1.09), driven by non-cash RINs and other mark-to-market items • Second Quarter 2026 Adjusted EBITDA with Tax Attributes of $175.2 mi

Original reporting
Published Aug 7, 2026, 12:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 12:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CLMT
Neutral
medium confidence
Mentioned
$CLMT
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CLMTNeutralMed
01

Why it matters

Traders can reassess Calumet’s earnings quality (non-cash RINs and derivatives), operating momentum in Specialty Products and Solutions, and balance-sheet risk after $115M debt retirement and redemption/repayment actions in July.

02

Market read

A primary earnings release with quantified adjusted EBITDA improvement and explicit July debt reduction, but GAAP losses remain large due to non-cash RINs and mark-to-market items.

03

What to watch

Segment-level gross profit per barrel swings and LIFO/feedstock impacts could matter more than headline adjusted EBITDA for near-term earnings quality.

Relevance 7/10Novelty 7/10Timing: pre-market today (8-K filed Aug 7, 2026)
alphai · Earnings readCLMT · Second Quarter 2026 · ended June 30, 2026

Calumet Reports Second Quarter 2026 Results

Mixed quarter

Specialty Products and Solutions delivered materially higher adjusted profitability in a favorable margin environment and the company advanced debt reduction, but Calumet reported a net loss of $(95.9) million and Performance Brands Adjusted EBITDA declined from the prior-year quarter.

Revenue
87,722

Key metrics

as reported
MetricValueq/qy/y
Net income (loss), three months ended June 30GAAP$ (95.9)
Basic earnings per common share, three months ended June 30GAAP$ (1.09)
Adjusted EBITDA, three months ended June 30non-GAAP$ 159.3
Adjusted EBITDA with Tax Attributes, three months ended June 30non-GAAP$ 175.2
Net income (loss), six months ended June 30GAAP$ (412.9)
Basic earnings per common share, six months ended June 30GAAP$ (4.73)
Adjusted EBITDA, six months ended June 30non-GAAP$ 186.9
Adjusted EBITDA with Tax Attributes, six months ended June 30non-GAAP$ 225.3
Specialty Products and Solutions gross profit (loss), three months ended June 30GAAP$ 31.8
Specialty Products and Solutions adjusted gross profit (loss), three months ended June 30non-GAAP$ 195.6
Specialty Products and Solutions Adjusted EBITDA, three months ended June 30non-GAAP$ 161.7
Specialty Products and Solutions Adjusted EBITDA with Tax Attributes, three months ended June 30non-GAAP$ 161.7
Specialty Products and Solutions gross profit (loss) per barrel, three months ended June 30GAAP$ 5.25
Specialty Products and Solutions adjusted gross profit (loss) per barrel, three months ended June 30non-GAAP$ 32.25
Performance Brands gross profit (loss), three months ended June 30GAAP$ 16.9
Performance Brands adjusted gross profit (loss), three months ended June 30non-GAAP$ 16.1
Performance Brands Adjusted EBITDA, three months ended June 30non-GAAP$ 6.3
Performance Brands Adjusted EBITDA with Tax Attributes, three months ended June 30non-GAAP$ 6.3
Performance Brands gross profit (loss) per barrel, three months ended June 30GAAP$ 85.47
Performance Brands adjusted gross profit (loss) per barrel, three months ended June 30non-GAAP$ 81.42
Montana/Renewables gross profit (loss), three months ended June 30GAAP$ (30.4)
Montana/Renewables adjusted gross profit (loss), three months ended June 30non-GAAP$ 19.5
Montana/Renewables Adjusted EBITDA, three months ended June 30non-GAAP$ 10.7
Montana/Renewables Adjusted EBITDA with Tax Attributes, three months ended June 30non-GAAP$ 26.6
Montana/Renewables gross profit (loss) per barrel, three months ended June 30GAAP$ (17.67)
Montana/Renewables adjusted gross profit (loss) per barrel, three months ended June 30non-GAAP$ 11.36
Corporate costs, Adjusted EBITDA, three months ended June 30non-GAAP$(19.4) million
Total sales volume, three months ended June 30other87,722
Total Specialty Products and Solutions facility production, three months ended June 30other62,903
Total Montana/Renewables facility production, three months ended June 30other18,124
Performance Brands facility production, three months ended June 30other2,164
Total facility production, three months ended June 30other83,191
Total sales volume, six months ended June 30other87,377
Total Specialty Products and Solutions facility production, six months ended June 30other59,282
Total Montana/Renewables facility production, six months ended June 30other18,630
Performance Brands facility production, six months ended June 30other1,945
Total facility production, six months ended June 30other79,857

What drove it

  • Specialty Products and Solutions results reflected a constructive market underpinned by a global shortage in specialty products, strong production, and excellent commercial execution.
  • Performance Brands reported strong volumes and record quarterly sales of TruFuel®.
  • Performance Brands results were partially offset by compressed margins as price increases were implemented during the quarter after a normal price lag, while feedstock costs escalated immediately with $7.3 million of LIFO impact to the segment.
  • The renewables business completed its planned turnaround and MaxSAF® 150 expansion work that began in March and lasted through April, then restarted operations in early May with a strong renewables margin environment.
  • The second-quarter net loss was significantly impacted by an unrealized gain of $9.0 million for derivatives and non-cash RINs related expense of $163.6 million.

Concerns

  • Calumet reported a second-quarter net loss of $(95.9) million and a six-month net loss of $(412.9) million.
  • Performance Brands Adjusted EBITDA was $6.3 million, compared to $13.5 million in the second quarter of 2025.
  • Montana/Renewables reported GAAP gross profit (loss) of $ (30.4) million despite adjusted gross profit (loss) of $ 19.5 million and Adjusted EBITDA with Tax Attributes of $ 26.6 million.
  • The filing cited non-cash RINs related expense of $163.6 million as a significant impact on second-quarter net loss.

What to watch

  • Specialty Products and Solutions market conditions, production, and commercial execution amid the cited global shortage in specialty products.
  • Performance Brands margin recovery following price increases, feedstock-cost escalation, and the reported $7.3 million of LIFO impact.
  • Montana Renewables operational performance after its early-May restart and progress toward the next stage of the MaxSAF® 150 expansion.
  • Further use of cash from operations to pay down debt in future periods.

Balance sheet and cash flow

  • On July 15, 2026, the Issuers redeemed all of the outstanding $100 million 9.75% Senior Notes due 2028 at a cash redemption price of 102.438% of the principal amount, plus accrued and unpaid interest up to but not including the redemption date.
  • On July 31, 2026, Calumet fully repaid and terminated the Montana terminal asset financing arrangement for cash consideration of $15.5 million.
  • Calumet reported $115 million of debt retirement in July.

Analysis

Calumet's second-quarter operating performance was led by Specialty Products and Solutions. The segment reported Adjusted EBITDA of $161.7 million, compared with $66.8 million in the same quarter a year ago, while adjusted gross profit was $195.6 million compared with $75.6 million. Management attributed the result to a constructive market, a global shortage in specialty products, strong production, and commercial execution. Total Specialty Products and Solutions facility production was 62,903 bpd, compared with 55,704 bpd.

The consolidated GAAP result remained a loss. Net income (loss) was $ (95.9), and basic earnings per common share was $ (1.09). The company identified non-cash RINs related expense of $163.6 million and an unrealized gain of $9.0 million for derivatives as significant non-cash items affecting the quarterly net loss. Consolidated Adjusted EBITDA was $159.3 million, compared with $55.1 million, and Adjusted EBITDA with Tax Attributes was $175.2 million, compared with $76.5 million.

Performance Brands was the principal operating offset. Its Adjusted EBITDA was $6.3 million versus $13.5 million in the prior-year quarter, while adjusted gross profit was $16.1 million versus $22.3 million. Management cited strong volumes and record quarterly TruFuel® sales, but described compressed margins from normal pricing lag and immediate feedstock-cost escalation, including $7.3 million of LIFO impact. Montana/Renewables restarted operations in early May after its planned turnaround and first-stage MaxSAF® 150 expansion work, producing Adjusted EBITDA with Tax Attributes of $26.6 million compared with $16.3 million.

Capital allocation centered on deleveraging after quarter-end. On July 15, 2026, the company redeemed all outstanding $100 million 9.75% Senior Notes due 2028 at a cash redemption price of 102.438% of principal, plus accrued and unpaid interest. It then fully repaid and terminated the Montana terminal asset financing arrangement on July 31, 2026 for cash consideration of $15.5 million. No formal financial guidance was provided in the filing, so the near-term focus is the durability of specialty margins, Performance Brands pricing and cost recovery, Montana Renewables execution after restart, and continuing debt reduction.

The filing does not provide prior-quarter financial comparisons, leaving quarter-over-quarter changes unreported. It also does not report consolidated or segment revenue, gross margin, operating income, cash flow, cash balances, debt balances, capital expenditures, or a quantitative outlook. Those omissions limit assessment of revenue mix, cash conversion, leverage after the July transactions, and the scale or timing of forward operating expectations.

Management, verbatim

Calumet continues to execute against every element of our multi-dimensional strategy.

Todd Borgmann, CEO

Our integrated specialties platform delivered exceptional results in a strong margin environment, supporting $115 million of debt retirement in July.

Todd Borgmann, CEO

Combined, our operating momentum and favorable outlook position us to simultaneously accelerate deleveraging and advance our growth strategies across both businesses.

Todd Borgmann, CEO

Not in the filing

stated, not guessed
  • Consolidated revenue
  • Segment revenue
  • Consolidated gross profit
  • Consolidated gross margin
  • Segment gross margins
  • Operating income or loss
  • Operating expenses
  • Net income attributable to common shareholders
  • Diluted earnings per common share
  • Non-GAAP earnings per share
  • Prior-quarter comparisons for reported financial and operating metrics
  • Cash from operations
  • Free cash flow
  • Cash balance
  • Debt balance
  • Capital expenditures
  • Dividend information
  • Share repurchases
  • Quantitative financial guidance
  • Previous-quarter outlook for guidance comparison
  • Six-month segment financial metrics and per-barrel metrics were reported in the filing but are not included in key_metrics due to the absence of a complete continuing filing text beyond the supplied excerpt
  • Individual facility production categories for lubricating oils, solvents, waxes, fuels, asphalt and other by-products, and renewable fuels were reported in the filing but are not included in key_metrics due to the absence of a complete continuing filing text beyond the supplied excerpt

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

SEC Form 8-K Item 2.02 reporting Calumet’s Q2 2026 results and financial condition, including segment performance and recent debt/financing actions.

Company-level read

Ticker impact

$CLMTNeutralMedium confidence
Context

Calumet reports Q2 2026 net loss of $95.9M, but highlights $175.2M adjusted EBITDA with tax attributes and $115M debt retirement in July.

Expected impact

Likely choppy reaction: investors may focus on adjusted EBITDA strength and debt paydown, while discounting GAAP loss driven by non-cash RINs and mark-to-market items.

Evidence & confidence

This is a primary SEC 8-K earnings release with multiple actionable datapoints (adjusted EBITDA, segment performance, and specific debt redemption/repayment actions). However, the article does not provide forward guidance or a new capital plan, limiting conviction on direction and magnitude.

Market effects

May signal improving margins/market tightness in specialty products and renewables, relevant to refiners and renewable fuels sentiment.

Limited, company-specific disclosure with no stated regional policy or demand shock.

Low, no international regulatory or macro catalyst beyond commodity-linked items and renewables economics.

Counterpoint

Adjusted EBITDA strength may be partially offset by ongoing volatility in RINs and mark-to-market derivatives, so equity upside could fade if those non-cash drivers reverse.

Key entities

  • Calumet, Inc.

    NASDAQ-listed specialty products and renewable fuels company reporting Q2 2026 results and deleveraging actions.

  • Montana Renewables

    Renewables segment completing the first phase of MaxSAF 150 expansion and restarting operations in May.

  • Calumet Specialty Products Partners, L.P.

    Wholly owned subsidiary that redeemed $100M 9.75% Senior Notes due 2028 at a 102.438% redemption price.

Every CLMT earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$CLMTMed

S&P upgrades Calumet rating to B- on stronger earnings

S&P Global Ratings upgraded Calumet Inc. to 'B-' from 'CCC+' due to stronger earnings in H1 2026 and improved credit metrics. The company's earnings grew on high margins for specialty oils and renewable fuels. S&P expects adjusted debt to EBITDA of 6x-7x in the next 12 months. Calumet redeemed $100M in senior unsecured notes in July 2026 and plans to expand sustainable aviation fuel production.

$CLMTMedAI 8/10

Calumet (CLMT) Q2 2026 Earnings Call Transcript

Calumet (CLMT) reported Q2 2026 Adjusted EBITDA with Tax Attributes of $175.2 million, driven by Specialty Products and Solutions at $161.7 million. Net loss was $95.9 million, mainly from non-cash RINs expenses of $163.6 million. The company said it repaid $115 million of debt in July, including $100 million note redemption, and discussed SAF expansion and hedges.

$CLMTMed

Why Calumet Stock Is Rocketing Higher Today

Calumet (CLMT) shares rose 15.2% to about $5.99 by 2:36 p.m. ET after a 6.8% drop the prior week. Bank of America kept a buy rating and raised its price target to $45 from $38, citing stronger free cash flow and debt retirement. Calumet reported about $54M free cash flow in Q2 2026 and retired $115M debt in July.

$CLMTMedAI 8/10

CLMT Stock Jumps As Revenue Beats And Debt Falls

Calumet Inc (NASDAQ: CLMT) shares rose about 10.56% after Q2 results and guidance. The company reported Q2 revenue of $1.45B versus a FactSet estimate of $1.12B, with EPS improving to -$1.09 from -$1.70. Operating cash flow was about $92.3M and free cash flow about $54M, alongside $115M debt reduction in July. Goldman Sachs raised its CLMT price target to $40 from $36 but kept a Neutral rating.

$CLMTMed

CLMT Stock Jumps As Revenue Beat Fuels Deleveraging Story

Calumet Inc. (CLMT) shares rose about 10.56% after the company reported Q2 revenue of $1.45B versus $1.12B expected, and narrowed its EPS loss to -$1.09 from -$1.70. The quarter included $54M free cash flow and management cited $115M debt reduction in July, alongside a MaxSAF 150 expansion at Montana Renewables.

$CLMTMed

Why Calumet Stock Flopped on Friday

Calumet (CLMT) shares fell about 6% on Friday after its Q2 earnings showed a surprise net loss. Revenue rose to just under $1.45B, up about 41% YoY, but adjusted net loss was $95.9M, or $1.09/share, versus a year-ago deficit of $147.9M. Analysts expected profit of $0.17/share. Long-term debt exceeded $2.2B.